Medications impacting brain function are commonly prescribed to older adults, but they can sometimes do more harm than good. Drugs like antipsychotics, sleep aids, and anxiety medications may cause side effects such as confusion, falls, and memory decline.
These dangers are especially significant for individuals already experiencing cognitive issues, including dementia. A recent UCLA study published in JAMA Network Open sheds light on where these medications typically start and why they continue to be used.
The research tracked over a thousand seniors across the United States over multiple years. The goal was to identify the initial points of prescription for drugs that influence cognition and to examine how long patients kept using them.
Results revealed that many of these prescriptions are not initiated in standard doctor’s offices. Instead, they often begin in hospitals, emergency rooms, and nursing homes—places where patients might be facing acute health problems or recovering from illness.
This is critical because decisions made in these settings can have lasting impacts. Once a medication is started, it often keeps being used even after patients return home. The study found that a significant number of individuals continued taking these drugs one year after they were first prescribed.
Particularly troubling were findings related to patients with dementia. They were more likely to be prescribed these medications and to sustain their use over time. For instance, over half of the dementia patients who began taking such drugs were still on them a year later.
The study also indicated that these medications are more frequently prescribed in hospital settings than expected, based on patient visits. This pattern suggests that hospitals and similar facilities may play a key role in initiating treatments with potential long-term risks.
These insights could help improve healthcare practices. By focusing on where prescriptions originate, medical systems can develop strategies to lessen unnecessary medication use. Measures might include reviewing medications before discharge or establishing clearer guidelines for prescribing.
The research raises important questions about why these medications are initially prescribed. Prior studies indicate many prescriptions for brain-affecting drugs lack a clear medical justification, implying some patients might be on medications they don’t truly need.
There are limitations to the study, such as the inability to always verify the exact origin of prescriptions, but overall, the trends observed are consistent and compelling.
In summary, hospitals and similar care environments are key points where medications affecting brain health are often started. These drugs frequently remain in use long after the initial prescription, especially among dementia patients.
Understanding this pattern allows clinicians and policymakers to implement better measures, aiming to reduce risks and enhance care for older adults. Future strategies should prioritize safer, more deliberate prescribing—especially in high-risk healthcare settings.
If you’re interested in dementia prevention, explore studies suggesting that eating apples and drinking tea might help delay its onset, along with the benefits of daily olive oil intake for brain health.
For additional health insights, check recent research on how combined eating habits could influence dementia risk or how time-restricted eating offers a straightforward approach to combat aging and cancer.
Source: University of California, Los Angeles.
